Up to 90% of HNSCC tumors overexpress EGFR [30], activating key intracellular signaling pathways such as MEK/ERK and PI3K/AKT, which promote cellular proliferation, survival, invasion, and metastasis [31,32]. This evidence concerns the gene MAPK1 and head and neck squamous cell carcinoma.